Cambridge Investment Research Advisors, Inc. Caribou Biosciences, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 582,387 shares of CRBU stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
582,387
Previous 584,446
0.35%
Holding current value
$1.18 Million
Previous $736,000
84.38%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRBU
# of Institutions
123Shares Held
39.9MCall Options Held
42.2KPut Options Held
93.2K-
Black Rock Inc. New York, NY6.95MShares$14.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.23MShares$8.58 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$6.53 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.07MShares$6.23 Million0.6% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$3.67 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $124M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...